Intellectual Property India Publishes Patent Application for 'Materials And Methods For Characterizing Potency' Filed by Encoded Therapeutics, Inc.

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517065112 A) filed by Encoded Therapeutics, Inc., San Francisco, on July 8, for 'materials and methods for characterizing potency.'

Inventor(s) include Tanenhaus, Anne; Wood, Sirika; Zhang, Chi; Bole, Dhruv; Cai, Tiffany; and Tan, Steven.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "The disclosure provides a nucleic acid comprising a response element operably linked to a reporter nucleotide sequence. In various embodiments, the response element comprises from 2 to 10 copies of a Z1 transcription factor binding site. Cells comprising the nucleic acid also are provided. In various aspects, the cells stably overexpress an adeno-associated virus receptor. The disclosure further provides a method of determining the potency of a sample comprising AAV vectors."

The patent application was internationally filed on Dec. 28, 2023, under International application No.PCT/US2023/086270.

Disclaimer: Curated by HT Syndication.